Group 1: Amazon and BETA Technologies - Amazon has acquired a 5.3% stake in BETA Technologies, leading to a nearly 19% increase in BETA's shares premarket [4][5] Group 2: Moderna - Moderna's shares fell 9% in premarket trading after the FDA refused to file its application for the mRNA-1010 influenza vaccine, citing inadequate trial controls [6][8] - The FDA's refusal was based on the application not reflecting the best-available standard of care during the study, although no specific safety or efficacy concerns were identified [7] - Moderna plans to meet with FDA officials to clarify the next steps but does not anticipate an impact on its 2026 financial guidance [8] Group 3: Estée Lauder and Walmart - Estée Lauder is suing Walmart for selling counterfeit products on its platform, claiming that Walmart facilitated these sales despite not selling the products directly [9][10] - The lawsuit alleges that Walmart allowed the use of Estée Lauder's trademarks in search engines, profiting from counterfeit sales [10]
Wall Street Breakfast Podcast: Amazon Adds BETA To Cart